{"id":"efe98b27-ff19-5621-b07e-61d1808cf03e","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:nattokinase-lowers-red-cell-aggregation","predicate":"reduces","statement":"Incubating blood with nattokinase produced a significant dose-dependent decrease in red blood cell aggregation.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"5676de00-ec79-5821-bad1-d6085cb5b40f","mechanism_event_label":"Incubating blood with nattokinase produced a significant dose-dependent decrease in red blood cell aggregation.","subject":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"object":{"id":"7bf028d4-85f9-583b-87b4-1212290cf49b","slug":"red-blood-cell-aggregation","display_name":"Red blood cell aggregation","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"5676de00-ec79-5821-bad1-d6085cb5b40f","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:nattokinase-lowers-red-cell-aggregation-event","event_type":"biochemical_relationship","label":"Incubating blood with nattokinase produced a significant dose-dependent decrease in red blood cell aggregation.","description":"Myrenne aggregometry","status":"provisional","compartment":null,"participants":[{"entity":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"7bf028d4-85f9-583b-87b4-1212290cf49b","slug":"red-blood-cell-aggregation","display_name":"Red blood cell aggregation","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"30 min at 37 C","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human blood ex vivo","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nattokinase at 15.6, 31.3, 62.5 and 125 units/mL","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The units here are the study's own and are not FU, CU or IU. They cannot be mapped onto an oral dose or a plasma concentration, so this result does not bridge to the human trials.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Human blood ex vivo","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Incubating blood with nattokinase produced a significant dose-dependent decrease in red blood cell aggregation.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. (2006) https://pubmed.ncbi.nlm.nih.gov/16899918/","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vitro","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Myrenne aggregometry","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"78cedb83-74d1-59c1-b7a0-3707d0a7f678","evidence_kind":"source_excerpt","locator":"Lines 378-378","start_line":378,"end_line":378,"excerpt":"Incubating blood with nattokinase produced a significant dose-dependent decrease in red blood cell aggregation.","model_system":"Human blood ex vivo","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}